Form 4: Vaxcyte CEO Grant Pickering Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Vaxcyte's CEO, Grant Pickering, executed multiple sales of common stock on June 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Grant Pickering, CEO of Vaxcyte, Inc. (PCVX), reported the sale of common stock on June 3, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on June 26, 2023.
- Multiple transactions occurred at varying prices, ranging from $70.98 to $73.46 per share.
- A total of 2,599 shares were sold directly by Pickering.
- Following the reported transactions, Pickering directly owns 478,888 shares.
- Pickering also indirectly owns shares through children's trusts, with the holdings fluctuating slightly after each sale.
- The filing also notes an adjustment to account for 1,041 shares acquired under the Employee Stock Purchase Plan on May 17, 2024, which were previously omitted from a prior filing.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock sales by an executive. The sales were conducted under a pre-arranged plan, suggesting no particular negative sentiment. The correction of a previous omission is a neutral factor.
Industry Context
Sales by executives are a normal part of corporate governance. It is important to note that the sales were executed under a pre-arranged 10b5-1 trading plan, which is a common practice to avoid accusations of insider trading.
Key Dates
| Date | Description |
|---|---|
| 2023-06-26 | Date of adoption of Rule 10b5-1 trading plan. |
| 2024-05-17 | Date of acquisition of shares under the Employee Stock Purchase Plan. |
| 2024-06-03 | Date of stock sale transactions. |
| 2024-06-05 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.